Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
WA Kaolin Ltd. ( (AU:WAK) ) has issued an announcement.
WA Kaolin Limited has launched a partially underwritten pro-rata non-renounceable entitlement offer to raise up to about $34.9 million, issuing up to roughly 3.49 billion new shares at $0.01 each, with one free option for every two new shares. The raising includes a shortfall offer and a separate grant of 40 million options to the lead manager, and is subject to shareholder approval and a minimum subscription, signalling a significant recapitalisation effort that could materially affect its capital structure and funding flexibility.
The offer is underwritten to $10.13 million through debt conversion by partial underwriters, which would reduce the company’s indebtedness if completed and align creditor interests with equity holders. The transaction is framed as highly speculative and targeted at existing eligible shareholders in Australia and certain New Zealand investors, underscoring both the company’s capital needs and the risk profile that current and prospective investors must weigh when considering participation.
The most recent analyst rating on (AU:WAK) stock is a Sell with a A$0.03 price target. To see the full list of analyst forecasts on WA Kaolin Ltd. stock, see the AU:WAK Stock Forecast page.
More about WA Kaolin Ltd.
WA Kaolin Limited is an Australian resources company focused on the exploration and production of kaolin, a key industrial mineral used in ceramics, paper, paints and other manufacturing applications. The company is listed on the ASX and targets investors seeking exposure to industrial minerals and specialty materials used in a range of downstream industries.
Average Trading Volume: 515,710
Technical Sentiment Signal: Sell
Current Market Cap: A$17.45M
See more data about WAK stock on TipRanks’ Stock Analysis page.

